A Fresh Look for Isaac Health: Introducing Our Rebrand

A new study reports that a blood test was 91% effective at diagnosing Alzheimer’s disease. What should I know?

Healthy body, healthy mind: Belly fat and muscle can impact brain health

Does anxiety increase risk for dementia? Making sense of the latest research findings

FDA Approval of Donanemab Marks Major Advance in Alzheimer’s Treatment

Independent advisors to the FDA recommend Eli Lilly’s Alzheimer’s drug donanemab

How the microbiome in your gut might influence your brain health

Isaac Health joins ALZ-NET as a participating telehealth site

CMS Launches New Dementia Care Management Program

New Drug Donanemab Shows Promise: Advancements in Early Alzheimer’s Treatment

White Paper on cost implications of Leqembi and other anti-amyloid drugs for payers and ACOs and options for utilization management

Introducing Leqembi: What You Need to Know About This Breakthrough in the Fight Against Alzheimer’s Disease

FAQ About Leqembi